CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 1 filers reported holding CONATUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2018 | $11,000 | -54.2% | 8,255 | +50.1% | 0.00% | 0.0% |
| Q2 2018 | $24,000 | +50.0% | 5,500 | +59.2% | 0.00% | 0.0% |
| Q1 2018 | $16,000 | 0.0% | 3,455 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $16,000 | -48.4% | 3,455 | -38.0% | 0.00% | 0.0% |
| Q3 2017 | $31,000 | +93.8% | 5,575 | +106.5% | 0.00% | 0.0% |
| Q2 2017 | $16,000 | +300.0% | 2,700 | +285.7% | 0.00% | – |
| Q1 2017 | $4,000 | -50.0% | 700 | -56.2% | 0.00% | – |
| Q4 2016 | $8,000 | +700.0% | 1,600 | +128.6% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -50.0% | 700 | 0.0% | 0.00% | – |
| Q4 2015 | $2,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,192,080 | $6,282,000 | 2.96% |
| COURAGE CAPITAL MANAGEMENT LLC | 100,000 | $527,000 | 0.33% |
| Crawford Lake Capital Management, LLC | 69,100 | $364,000 | 0.26% |
| Hall Kathryn A. | 31,355 | $166,000 | 0.20% |
| ELLINGTON MANAGEMENT GROUP LLC | 29,300 | $154,000 | 0.02% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $116,000 | 0.02% |
| Virtu KCG Holdings LLC | 150,357 | $792,000 | 0.02% |
| THOMPSON DAVIS & CO., INC. | 2,000 | $11,000 | 0.02% |
| Jasper Ridge Partners, L.P. | 47,481 | $250,000 | 0.02% |
| AXA S.A. | 479,686 | $2,528,000 | 0.01% |